[go: up one dir, main page]

TW200738239A - Stable solid formulation of sertindole - Google Patents

Stable solid formulation of sertindole

Info

Publication number
TW200738239A
TW200738239A TW095130202A TW95130202A TW200738239A TW 200738239 A TW200738239 A TW 200738239A TW 095130202 A TW095130202 A TW 095130202A TW 95130202 A TW95130202 A TW 95130202A TW 200738239 A TW200738239 A TW 200738239A
Authority
TW
Taiwan
Prior art keywords
sertindole
solid formulation
stable solid
pharmaceutical composition
relates
Prior art date
Application number
TW095130202A
Other languages
English (en)
Chinese (zh)
Inventor
Flemming Enok Olsen
Anne Ravnholdt Christensen
Ken Liljegren
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW200738239A publication Critical patent/TW200738239A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095130202A 2005-09-08 2006-08-17 Stable solid formulation of sertindole TW200738239A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200501255 2005-09-08

Publications (1)

Publication Number Publication Date
TW200738239A true TW200738239A (en) 2007-10-16

Family

ID=37697999

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095130202A TW200738239A (en) 2005-09-08 2006-08-17 Stable solid formulation of sertindole

Country Status (17)

Country Link
EP (1) EP1924261A1 (uk)
JP (1) JP2009507051A (uk)
KR (1) KR20080042102A (uk)
CN (1) CN101257906A (uk)
AR (1) AR056475A1 (uk)
AU (1) AU2006322460A1 (uk)
BR (1) BRPI0615630A2 (uk)
CA (1) CA2621866A1 (uk)
EA (1) EA013167B1 (uk)
IL (1) IL189541A0 (uk)
MX (1) MX2008002290A (uk)
NO (1) NO20081721L (uk)
NZ (1) NZ565330A (uk)
TW (1) TW200738239A (uk)
UA (1) UA97349C2 (uk)
WO (1) WO2007065448A1 (uk)
ZA (1) ZA200801169B (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
US20110305758A1 (en) * 2009-01-29 2011-12-15 Mitsuhiro Matono Orally disintegrating tablet having inner core
FR2943061B1 (fr) * 2009-03-13 2011-02-25 Rhodia Operations Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
SMT202200095T1 (it) 2012-07-16 2022-03-21 Fibrogen Inc Forme cristalline di un inibitore di prolil idrossilasi
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
SI3003284T1 (sl) 2013-06-06 2020-08-31 Fibrogen, Inc. Farmacevtske formulacije inhibitorja HIF hidroksilaze
CA2930461C (en) 2013-11-19 2022-08-16 Siga Technologies, Inc. Rehydration of micronized tecovirimat monohydrate
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
EP0906104A4 (en) * 1996-03-25 2003-12-10 Lilly Co Eli PAIN TREATMENT PROCESS
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
AR056475A1 (es) 2007-10-10
BRPI0615630A2 (pt) 2016-11-16
MX2008002290A (es) 2008-03-14
IL189541A0 (en) 2008-08-07
NZ565330A (en) 2011-06-30
EA200800774A1 (ru) 2008-06-30
NO20081721L (no) 2008-04-08
ZA200801169B (en) 2010-07-28
CN101257906A (zh) 2008-09-03
JP2009507051A (ja) 2009-02-19
EP1924261A1 (en) 2008-05-28
UA97349C2 (uk) 2012-02-10
KR20080042102A (ko) 2008-05-14
CA2621866A1 (en) 2007-06-14
AU2006322460A1 (en) 2007-06-14
EA013167B1 (ru) 2010-02-26
WO2007065448A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2006107451A3 (en) Honokiol derivatives for the treatment of proliferative disorders
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
IL186303A (en) 1h - benzamideimzole - 4 carboxyamides converted with quarterly carbon in position 2, the pharmaceutical composition containing it and its use for the preparation of a drug @ for the treatment @ of cancer
JP2006519866A5 (uk)
WO2008097640A8 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
WO2007100776A3 (en) Antimicrobial compositions and methods for locking catheters
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
WO2008092006A3 (en) Antimicrobial compositions
CL2007002234A1 (es) Compuestos derivados de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
JO2578B1 (en) Compounds Theophene benzimidazole
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
NO20081721L (no) Stabil fast formulering av sertindol
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CR10305A (es) "derivados sustituidos de cromanol y su uso.
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
CL2007003847A1 (es) Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer.
IN266834B (uk)
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments